Menopause Blood Test Panel 2
- $747.92
- $198.95
- Save: 73.40%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils
Absolute Basophils
Absolute Blasts
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes
Absolute Monocytes
Absolute Myelocytes
Absolute Neutrophils
Absolute Nucleated Rbc
Absolute Promyelocytes
Band Neutrophils
Basophils
Blasts
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes
Monocytes
MPV
Myelocytes
Neutrophils
Nucleated Rbc
Platelet Count
Promyelocytes
RDW
Reactive Lymphocytes
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Estradiol
Also known as: Estrogen Total Serum
Estrogen, Total, Serum
Also known as: Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH), Follicle Stimulating Hormone and Luteinizing Hormone
Fsh
Lh
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Thyroid Stimulating Hormone, Thyroid Stimulating Hormone (TSH), Thyrotropin
TSH
TSH
The Menopause Blood Test Panel 2 panel contains 7 tests with 66 biomarkers .
Menopause Blood Test Panel 2
The Menopause Blood Test Panel 2 is designed to assess hormonal and metabolic changes that occur during menopause. This panel provides valuable insights into estrogen levels, ovarian function, thyroid health, lipid metabolism, and overall metabolic status. Menopause is a natural transition in a woman's life, typically occurring in the late 40s or early 50s, marked by the cessation of menstrual cycles and significant hormonal fluctuations. This panel helps determine if a woman is in perimenopause or menopause and identifies potential health risks associated with hormonal changes, such as osteoporosis, cardiovascular disease, and metabolic disorders. By evaluating key biomarkers, healthcare providers can develop personalized treatment plans to support overall health and well-being during this life stage.
When and Why the Menopause Blood Test Panel 2 May Be Ordered
The Menopause Blood Test Panel 2 is typically ordered for women experiencing symptoms associated with menopause, including irregular menstrual cycles, hot flashes, night sweats, mood swings, fatigue, vaginal dryness, or unexplained weight changes. It may also be recommended for women with a family history of early menopause, those undergoing hormone replacement therapy (HRT), or individuals at risk of developing osteoporosis or cardiovascular disease. This panel is particularly useful for confirming the onset of menopause, differentiating between menopause and other hormonal disorders, and evaluating overall health risks associated with declining estrogen levels. Women seeking guidance on managing menopausal symptoms through lifestyle changes, dietary modifications, or hormone therapy may also benefit from this comprehensive assessment.
What the Menopause Blood Test Panel 2 Checks For
The Menopause Blood Test Panel 2 evaluates key biomarkers related to hormonal balance, ovarian function, thyroid health, metabolic status, and cardiovascular risk. Each test provides essential information about a woman's transition through menopause and overall health.
Hormonal Balance and Ovarian Function
Hormonal changes are central to menopause. This panel assesses key reproductive hormones that regulate ovarian function and influence menopause symptoms. Fluctuations in these hormones help determine whether a woman is in perimenopause, menopause, or experiencing another hormonal imbalance. Declining estrogen levels can contribute to bone loss, mood changes, and cardiovascular risks, while changes in follicle-stimulating hormone (FSH) and luteinizing hormone (LH) indicate the body's transition out of reproductive years.
Thyroid Function and Metabolic Regulation
Thyroid health is closely linked to menopause, as thyroid dysfunction can mimic menopause symptoms such as fatigue, weight gain, and mood swings. Evaluating thyroid hormone levels ensures that symptoms attributed to menopause are not due to an underlying thyroid disorder.
Cardiovascular and Metabolic Health
Menopause is associated with an increased risk of cardiovascular disease due to changes in lipid metabolism and insulin sensitivity. This panel includes an assessment of cholesterol levels and metabolic function to identify early signs of heart disease or metabolic disorders. By evaluating lipid profiles, glucose levels, and overall metabolic status, healthcare providers can guide lifestyle and dietary changes to reduce long-term health risks.
Blood Health and Overall Well-Being
A complete blood count (CBC) provides insight into overall health, immune function, and potential anemia. Since menopausal women are at risk for iron-deficiency anemia due to heavy or prolonged menstrual bleeding before menopause, this test helps detect any abnormalities in red and white blood cell levels.
Conditions and Diseases the Menopause Blood Test Panel 2 Can Detect
This panel aids in detecting and monitoring several conditions that commonly affect menopausal women. Early detection allows for effective management and treatment strategies to improve quality of life and long-term health.
Menopause and Perimenopause
Menopause is defined as the cessation of menstrual cycles for 12 consecutive months, while perimenopause is the transitional phase leading up to menopause. This panel confirms menopause by measuring hormonal markers such as estrogen, FSH, and LH. Elevated FSH and LH levels, combined with declining estrogen levels, indicate the transition into menopause.
Osteoporosis Risk
Estrogen plays a crucial role in maintaining bone density. As estrogen levels decline during menopause, the risk of osteoporosis increases, leading to weaker bones and a higher likelihood of fractures. This panel helps identify women at risk by assessing metabolic markers and guiding recommendations for bone health management.
Cardiovascular Disease
Menopause is associated with an increased risk of cardiovascular disease due to changes in cholesterol levels and metabolic function. A decrease in estrogen can lead to higher LDL cholesterol ("bad cholesterol") and lower HDL cholesterol ("good cholesterol"), increasing the likelihood of heart disease. By evaluating lipid profiles, this panel helps assess cardiovascular risk and informs preventive strategies.
Thyroid Disorders
Thyroid dysfunction can mimic menopause symptoms, making it essential to differentiate between thyroid-related conditions and hormonal changes due to menopause. Abnormal TSH levels may indicate hypothyroidism or hyperthyroidism, both of which require treatment to restore metabolic balance.
Metabolic Syndrome and Type 2 Diabetes
Menopausal women are at increased risk of metabolic syndrome, which is characterized by high blood pressure, abnormal cholesterol levels, and insulin resistance. By assessing lipid metabolism and glucose regulation, this panel helps identify women at risk of developing type 2 diabetes and metabolic disorders.
How Healthcare Professionals Use the Menopause Blood Test Panel 2 in Treatment and Monitoring
Healthcare providers use this panel to guide treatment and monitoring strategies for menopausal symptoms and associated health risks.
Managing Menopause and Perimenopause
For women experiencing menopausal symptoms, hormone therapy (HT) may be recommended to alleviate symptoms such as hot flashes, mood swings, and vaginal dryness. Regular monitoring of hormone levels ensures that treatment is tailored to individual needs and minimizes potential risks.
Preventing and Managing Osteoporosis
If a woman is at risk for osteoporosis, healthcare providers may recommend calcium and vitamin D supplementation, weight-bearing exercises, and bone density testing. Hormone therapy may also be considered for women with significant bone loss.
Reducing Cardiovascular Disease Risk
If lipid panel results indicate high cholesterol levels, healthcare providers may suggest lifestyle changes, dietary modifications, and, in some cases, cholesterol-lowering medications to reduce cardiovascular risk. Regular monitoring of lipid levels ensures long-term heart health.
Treating Thyroid Disorders
If thyroid dysfunction is detected, treatment options may include thyroid hormone replacement for hypothyroidism or medications to regulate hyperthyroidism. Proper thyroid management can improve energy levels, mood, and overall well-being during menopause.
Addressing Metabolic Syndrome and Diabetes Risk
For women at risk of metabolic syndrome or type 2 diabetes, healthcare providers may recommend dietary changes, increased physical activity, and medications to improve insulin sensitivity. Regular monitoring of metabolic markers helps prevent the progression of metabolic disorders.
Conclusion
The Menopause Blood Test Panel 2 is a comprehensive assessment that evaluates hormonal balance, metabolic health, cardiovascular risk, and overall well-being during menopause. By analyzing key biomarkers such as estrogen, FSH, LH, thyroid hormones, lipid profiles, and metabolic markers, this panel provides valuable insights into the body's transition through menopause. Early detection and appropriate management of conditions such as osteoporosis, cardiovascular disease, thyroid disorders, and metabolic syndrome can help improve quality of life and long-term health outcomes for menopausal women. Healthcare providers use this panel to develop personalized treatment plans, ensuring that women navigate menopause with optimal health and well-being.